
tekamlo
Pharmaranks rates Tekamlo 3.5/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Tekamlo is a combination medicine containing Aliskiren Hemifumarate and Amlodipine Besylate.
Aliskiren Hemifumarate and Amlodipine Besylate · by Novartis
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Aliskiren Hemifumarate and Amlodipine Besylate
- Form
- Tablet
- Strength
- Aliskiren Hemifumarate EQ 150MG Base; Amlodipine Besylate EQ 10MG Base · Aliskiren Hemifumarate EQ 150MG Base; Amlodipine Besylate EQ 5MG Base · Aliskiren Hemifumarate EQ 300MG Base; Amlodipine Besylate EQ 10MG Base · Aliskiren Hemifumarate EQ 300MG Base; Amlodipine Besylate EQ 5MG Base
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- Manufacturer
- Novartis
- Half-life
- about 30 to 50 hours (how long it stays in your system)
- FDA application
- NDA022545
- Availability
- Discontinued (per FDA)
How long does Aliskiren Hemifumarate and Amlodipine Besylate stay in your body?
The elimination half-life of aliskiren hemifumarate and amlodipine besylate is about 30 to 50 hours — the time it takes the body to clear about half of it. As a rule of thumb, a medicine is mostly gone after roughly 4 to 5 half-lives, though this varies from person to person with age and kidney or liver function. This is the parent drug's terminal elimination half-life in adults with normal liver function; it is longer (about 56 hours) in people with impaired liver function, and elderly patients and those with liver problems or heart failure clear the drug more slowly (roughly 40 to 60% higher blood levels). Amlodipine's metabolites are inactive, so no active-metabolite caveat applies.
This is general information, not medical advice. It doesn’t tell you when a drug test would read negative (tests detect substances for different, often longer, windows) or when it’s safe to take another dose — ask your pharmacist or prescriber. Source: NORVASC (amlodipine besylate) tablets — FDA prescribing information, DailyMed.
Dosage forms
Tablet
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- How is Tekamlo rated?
- pharmaranks gives Tekamlo a composite score of 3.5 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Tekamlo?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Tekamlo. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Tekamlo?
- Tekamlo is marketed by Novartis. You can see Novartis's full profile, rating, and other products on pharmaranks.
- Is Tekamlo a brand-name or generic drug?
- Tekamlo is a brand-name product with the active ingredient Aliskiren Hemifumarate and Amlodipine Besylate.
- Is Tekamlo available over the counter?
- No. Tekamlo is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Tekamlo come in?
- Tekamlo is currently marketed as tablet, per the FDA's National Drug Code Directory.
- Is Tekamlo FDA-registered?
- Tekamlo is on record with the U.S. FDA under application number NDA022545. You can verify this on its official FDA label.
- Has Tekamlo been recalled by the FDA?
- Tekamlo has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Tekamlo safe?
- There's no single safe-or-not verdict. pharmaranks gives Tekamlo a recall-safety score of 70/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
Reviews
No reviews yet. Be the first to write one.
People also viewed
abiraterone acetate
Abiraterone Acetate
acular
Ketorolac Tromethamine
acular ls
Ketorolac Tromethamine
aimovig
Erenumab-Aooe
albendazole
Albendazole
alphagan p
Brimonidine Tartrate
Compare Tekamlo head-to-head
Guides for this medication
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
tekamlo
70/100